Patent · US Active

Methods for detecting gene dysregulation by intragenic differential expression

US9546404B2 · kind B2 · utility

14Cited by
10References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 29, 2015
Grant dateJan 17, 2017
Priority date
Expiry dateApr 29, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Described herein are methods, compositions and kits directed to the detection of gene dysregulations such as those arising from gene fusions and/or chromosomal abnormalities, e.g., translocations, insertions, inversions and deletions. Samples containing dysregulated gene(s) of interest may show independent expression patterns for the 5′ and 3′ regions of the gene. The methods, compositions and kits are useful for detecting mutations that cause the differential expression of a 5′ portion of a target gene relative to the 3′ region of the target gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.